Events

EANM 2026

Missed us at EANM 2026 in Vienna? Catch up on demand

Thank you to everyone who visited us at EANM 2026. If you couldn’t make it to Vienna, you can now watch our videos, download the presentation and posters, and read the latest EPIC-Skin publication.

The congress provided an opportunity to connect with the international nuclear medicine community and exchange insights on Rhenium-SCT, clinical evidence and the evolving role of targeted cutaneous radioisotope therapy in the treatment of non-melanoma skin cancer.

Explore our EANM 2026 resources below, including scientific presentations, educational materials, videos and further information about OncoBeta and Rhenium-SCT.

 

Video:

EANM 2026 Recap

Highlights from our time at EANM 2026 in Vienna.

Play video

 

Publication:

Baxi S, et al. 188Rhenium skin cancer therapy: Two-year efficacy, safety and patient-reported outcomes from the prospective, multicentre, phase IV, EPIC-skin study in non-melanoma skin cancer. EANM Innovation 2026; 5:100311.

Read the full paper (open access)

 

Video:

Dose modelling and application variability in Rhenium-SCT®

Presentation by F. Martin del Rosario: Monte Carlo investigation of dose modelling and application variability in rhenium-188 skin radionuclide therapy.

Play video

 

Video:

Building Bridges at EANM 2026: Multidisciplinary Management of Non-Melanoma Skin Cancer

Educational dinner with Dr. Sylvia Holle-Robatsch, MD (Vienna), Patient Selection, Referral Pathways and Follow-Up Care in Non-Melanoma Skin Cancer: The Dermatologist’s Perspective, and Prof. Siroos Mirzaei, MD (Vienna), Real-world experience with Rhenium-SCT and multidisciplinary patient selection in non-melanoma skin cancer from Vienna.

Play video

 

Presentation:

Monte Carlo investigation of dose modelling and application variability in rhenium-188 skin radionuclide therapy

Download PDF

 

Poster:

Rhenium-188 skin cancer therapy (SCT) European Subanalysis: Two-year efficacy and safety from a prospective multicentre phase IV study

Download PDF

 

Poster:

Rhenium-188 skin cancer therapy: two-year efficacy and safety from a prospective multicenter phase IV study with dermatology-directed assessment of skin findings (EPIC-Skin Trial)

Download PDF

 

Explore:

Explore Clinical evidence

Review published data, ongoing evidence generation initiatives and scientific publications supporting Rhenium-SCT®.

Read More

 

Explore:

Understand the Technology

Visit the Technology Hub to learn more about epidermal radionuclide therapy and the scientific principles behind Rhenium-SCT®.

Read More

 

This content is intended only for healthcare professionals practicing in regions where Rhenium-SCT® is approved.